• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Break (1069); Difficult to Insert (1316); Separation Failure (2547); Patient-Device Incompatibility (2682)
Patient Problems Irritation (1941); Device Embedded In Tissue or Plaque (3165)
Event Date 12/13/2017
Event Type  malfunction  
Event Description
This spontaneous case was reported by a physician and describes the occurrence of device breakage ("the coil broke in half (coil 1st)") in a (b)(6) year-old female patient who had essure (batch no.He01336) inserted for female sterilization.The occurrence of additional non-serious events is detailed below.Other product or product use issues identified: device difficult to use "after some difficulty, he was able to push the button, but then the coil did not detach so he tried to remove it" on (b)(6) 2017 and device use error "the tip of the coil was bent (coil 2)" on (b)(6) 2017.The patient's concurrent conditions included fallopian tube stenosis.On (b)(6) 2017, during attempt of essure insertion, the patient experienced device breakage (seriousness criterion medically significant), device deployment issue ("after some difficulty, he was able to push the button, but then the coil did not detach so he tried to remove it"), fallopian tube disorder ("irritation from first insertion attempt (coil 2nd)") and complication of device insertion ("hcp aborted the procedure").At the time of the report, the device breakage, device deployment issue, fallopian tube disorder and complication of device insertion outcome was unknown.The reporter provided no causality assessment for complication of device insertion, device breakage, device deployment issue and fallopian tube disorder with essure.The reporter commented: hcp was able to remove both pieces of essure.Incident: at the time of reporting, there is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Manufacturer Narrative
This spontaneous case was reported by a physician and describes the occurrence of device breakage ("the coil broke in half (coil 1st)") in a (b)(6) year-old female patient who had essure (batch no.He01336) inserted for female sterilization.The occurrence of additional non-serious events is detailed below.Other product or product use issues identified: device difficult to use "after some difficulty, he was able to push the button, but then the coil did not detach so he tried to remove it" on (b)(6) 2017 and device use error "the tip of the coil was bent (coil 2)" on (b)(6) 2017.The patient's concurrent conditions included fallopian tube stenosis.On an unknown date, the patient had essure inserted.On (b)(6) 2017, the patient experienced device breakage (seriousness criterion medically significant), device deployment issue ("after some difficulty, he was able to push the button, but then the coil did not detach so he tried to remove it"), fallopian tube disorder ("irritation from first insertion attempt (coil 2nd)") and complication of device insertion ("hcp aborted the procedure").At the time of the report, the device breakage, device deployment issue, fallopian tube disorder and complication of device insertion outcome was unknown.The reporter provided no causality assessment for complication of device insertion, device breakage, device deployment issue and fallopian tube disorder with essure.The reporter commented: hcp was able to remove both pieces of essure.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 09-jan-2018: quality-safety evaluation of ptc.Incident: at the time of reporting, there is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Manufacturer Narrative
Ntaneous case was reported by a physician and describes the occurrence of device breakage ("the coil broke in half (coil 1st)") in a 42-year-old female patient who had essure (batch no.He01336) inserted for female sterilization.The occurrence of additional non-serious events is detailed below.Other product or product use issues identified: device deployment issue "after some difficulty, he was able to push the button, but then the coil did not detach so he tried to remove it" on (b)(6) 2017, device difficult to use "after some difficulty, he was able to push the button, but then the coil did not detach so he tried to remove it" on (b)(6) 2017 and device use error "the tip of the coil was bent (coil 2)" on (b)(6) 2017.The patient's concurrent conditions included fallopian tube stenosis.On an unknown date, the patient had essure inserted.On (b)(6) 2017, the patient experienced device breakage (seriousness criterion medically significant), fallopian tube disorder ("irritation from first insertion attempt (coil 2nd)") and complication of device insertion ("hcp aborted the procedure").At the time of the report, the device breakage, fallopian tube disorder and complication of device insertion outcome was unknown.The reporter provided no causality assessment for complication of device insertion, device breakage and fallopian tube disorder with essure.The reporter commented: hcp was able to remove both pieces of essure.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 8-oct-2018: quality safety evaluation of ptc.Incident: at the time of reporting, there is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
MDR Report Key7137282
MDR Text Key96054312
Report Number2951250-2017-10968
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup,Followup
Report Date 10/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/28/2020
Device Model NumberESS305
Device Lot NumberHE01336
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received10/08/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age42 YR
-
-